117 related articles for article (PubMed ID: 10398139)
1. Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer.
Wagner U; Süess K; Luginbühl T; Schmid U; Ackermann D; Zellweger T; Maurer R; Alund G; Knönagel H; Rist M; Jordan P; Moch H; Mihatsch MJ; Gasser TC; Sauter G
J Pathol; 1999 May; 188(1):44-50. PubMed ID: 10398139
[TBL] [Abstract][Full Text] [Related]
2. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer.
Osman I; Scher H; Zhang ZF; Soos TJ; Hamza R; Eissa S; Khaled H; Koff A; Cordon-Cardo C
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2247-51. PubMed ID: 9815621
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
4. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters.
Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Requena MJ; Montironi R
Am J Clin Pathol; 2004 Sep; 122(3):444-52. PubMed ID: 15362377
[TBL] [Abstract][Full Text] [Related]
7. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression.
Mhawech P; Greloz V; Oppikofer C; Szalay-Quinodoz I; Herrmann F
Cancer; 2004 Jun; 100(11):2367-75. PubMed ID: 15160340
[TBL] [Abstract][Full Text] [Related]
8. Association between high initial tissue levels of cyclin d1 and recurrence of nasopharyngeal carcinoma.
Lai JP; Tong CL; Hong C; Xiao JY; Tao ZD; Zhang Z; Tong WM; Betz CS
Laryngoscope; 2002 Feb; 112(2):402-8. PubMed ID: 11889405
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).
Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Carrasco JC; Requena MJ; Montironi R
Eur Urol; 2004 May; 45(5):606-12. PubMed ID: 15082203
[TBL] [Abstract][Full Text] [Related]
10. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.
Kamai T; Takagi K; Asami H; Ito Y; Oshima H; Yoshida KI
Br J Cancer; 2001 May; 84(9):1242-51. PubMed ID: 11336477
[TBL] [Abstract][Full Text] [Related]
11. Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder.
Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
Urol Oncol; 2007; 25(6):468-75. PubMed ID: 18047954
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma.
Theodoropoulos VE; Lazaris AC; Kastriotis I; Spiliadi C; Theodoropoulos GE; Tsoukala V; Patsouris E; Sofras F
BJU Int; 2005 Feb; 95(3):425-31. PubMed ID: 15679808
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D3 expression in primary Ta/T1 bladder cancer.
Lopez-Beltran A; Requena MJ; Luque RJ; Alvarez-Kindelan J; Quintero A; Blanca AM; Rodriguez ME; Siendones E; Montironi R
J Pathol; 2006 May; 209(1):106-13. PubMed ID: 16482499
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value.
van Diest PJ; Michalides RJ; Jannink L; van der Valk P; Peterse HL; de Jong JS; Meijer CJ; Baak JP
Am J Pathol; 1997 Feb; 150(2):705-11. PubMed ID: 9033283
[TBL] [Abstract][Full Text] [Related]
15. Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.
Brambilla E; Moro D; Gazzeri S; Brambilla C
J Pathol; 1999 Aug; 188(4):351-60. PubMed ID: 10440744
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.
Popov Z; Gil-Diez-De-Medina S; Ravery V; Hoznek A; Bastuji-Garin S; Lefrere-Belda MA; Abbou CC; Chopin DK
Urol Oncol; 2004; 22(2):93-101. PubMed ID: 15082004
[TBL] [Abstract][Full Text] [Related]
17. Decreased p27(Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma.
Hui AM; Cui X; Makuuchi M; Li X; Shi YZ; Takayama T
Hepatology; 1999 Nov; 30(5):1167-73. PubMed ID: 10534337
[TBL] [Abstract][Full Text] [Related]
18. Superficial papillary urothelial carcinomas in young and elderly patients: a comparative study.
Migaldi M; Rossi G; Maiorana A; Sartori G; Ferrari P; De Gaetani C; Cittadini A; Trentini GP; Sgambato A
BJU Int; 2004 Aug; 94(3):311-6. PubMed ID: 15291858
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of CDC91L1 (PIG-U) in bladder urothelial cell carcinoma: correlation with clinical variables and prognostic significance.
Shen YJ; Ye DW; Yao XD; Trink B; Zhou XY; Zhang SL; Dai B; Zhang HL; Zhu Y; Guo Z; Wu G; Nagpal J
BJU Int; 2008 Jan; 101(1):113-9. PubMed ID: 17941920
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
